Professor SARAH LEWIS SARAH.LEWIS@NOTTINGHAM.AC.UK
Professor of Medical Statistics
Effect of 3 months and 12 months of financial incentives on 12-month postpartum smoking cessation maintenance: a randomised controlled trial
Lewis, Sarah; Mckell, Jennifer; Coleman, Tim; Cooper, Sue; Orton, Sophie; Bauld, Linda; Usher, John
Authors
Jennifer Mckell
TIM COLEMAN tim.coleman@nottingham.ac.uk
Professor of Primary Care
Sue Cooper
SOPHIE ORTON SOPHIE.ORTON@NOTTINGHAM.AC.UK
Senior Research Fellow
Linda Bauld
John Usher
Abstract
Background and aims
Offering financial incentives is effective for smoking cessation during pregnancy. We tested the effectiveness of financial incentives for maintaining postpartum cessation, comparing 12-month and 3-month incentives with each other and with usual care (UC).
Design, setting and participants
This study was a pragmatic, multi-centre, three-arm randomized controlled trial involving four English, National Health Service, stop smoking services. A total of 462 postpartum women (aged ≥ 16 years) took part, who stopped smoking during pregnancy with financial incentives, validated as abstinent from smoking at end of pregnancy or early postpartum.
Interventions
Interventions comprised (i) UC; (ii) UC plus up to £60 of financial voucher incentives offered to participants and £60 offered to an optional significant-other supporter, over 3 months postpartum, contingent upon validated abstinence (‘3-month incentives’); or (iii) UC plus ‘3-month incentives’ plus £180 of vouchers offered to participants over 9 months postpartum, contingent upon abstinence (‘12-month incentives’).
Measurements
Primary outcome: biochemically validated abstinence at 1 year postpartum. To adjust for testing all comparisons between groups with equal precision, P < 0.017 was necessary for significance. Secondary outcomes: self-reported and validated abstinence at 3 months postpartum; self-reported abstinence at 1 year postpartum.
Findings
Primary outcome ascertainment: abstinence was 39.6% (63/159) 12 months incentives, 21.4% (33/154) 3 months incentives and 28.2% (42/149) UC. Adjusted odds ratios [95% confidence interval (CI)] = 12-month versus 3-month incentives OR = 2.41 (95% CI = 1.46−3.96), P = 0.001; 12 months versus UC 1.67 (1.04−2.70), P = 0.035; 3 months versus UC 0.69 (0.41−1.17), P = 0.174. Bayes factors indicated that for 12-month versus 3-month incentives and 12 months versus UC there was good evidence for the alternative hypothesis, and for 3 months versus UC there was good evidence for the null hypothesis.
Conclusions
This randomized controlled trial provides weak evidence that up to £300 of voucher incentives over 12 months is effective for maintaining smoking abstinence postpartum compared with usual care. There was good evidence that 12-month incentives are superior to those over only 3 months, for which there was no evidence of effectiveness relative to usual care.
Citation
Lewis, S., Mckell, J., Coleman, T., Cooper, S., Orton, S., Bauld, L., & Usher, J. (2024). Effect of 3 months and 12 months of financial incentives on 12-month postpartum smoking cessation maintenance: a randomised controlled trial. Addiction, 119(8), 1352-1363. https://doi.org/10.1111/add.16487
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 28, 2024 |
Online Publication Date | Apr 16, 2024 |
Publication Date | 2024-08 |
Deposit Date | Feb 29, 2024 |
Publicly Available Date | Feb 29, 2024 |
Print ISSN | 0965-2140 |
Electronic ISSN | 1360-0443 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 119 |
Issue | 8 |
Pages | 1352-1363 |
DOI | https://doi.org/10.1111/add.16487 |
Public URL | https://nottingham-repository.worktribe.com/output/31892711 |
Publisher URL | https://onlinelibrary.wiley.com/doi/10.1111/add.16487 |
Files
Addiction - 2024 - Ussher - Effect of 3 months and 12 months of financial incentives on 12‐month postpartum smoking
(1.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Characterizing tobacco control mass media campaigns in England
(2013)
Journal Article
A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search